-
FDA Grants Expanded Indication for AMVUTTRA® (vutrisiran) in the U.S.
Now available to treat a new group of patients
Learn More ›
-
FDA Approves Qfitlia™ (fitusiran)
In partnership with Sanofi, this is our 6th Alnylam-discovered approval in the U.S.
Learn More ›
-
2024 Year in Review and a Look Ahead
CEO Yvonne Greenstreet Highlights a Pivotal Year for Alnylam
Learn More ›
-
Alnylam Named a Most Responsible Company by Newsweek
We are honored to be recognized for the third year in a row
Learn More ›
-
Alnylam Named a Top Science Employer by Science Magazine
This is our 6th consecutive year on the Science Magazine Top Employer list
Learn More ›